ARCHIVES

Kadcyla Extends Median PFS In Open-Label Phase III Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Kennedy Plans One Year Act Renewal, Followed By Three Year Bill; Hearing Scheduled Feb. 8

February 3, 1978

New Protocol Could Improve Survival Of Rare Brain Tumor

October 30, 2009

Kessler Says FDA Working To Expedite Secondary Approvals

January 31, 1992

Katterhagen Predicts Increase Support From State, Local sources, Sees It As Community Challenge

March 27, 1981

Clinical Trials: ECOG Says Results In Metastatic disease equivalent, Unlikely To change Over Time

April 16, 1999

Golde To Step Down At MSK; Porter Joins Hogan & Hartson.

January 26, 2001